Your browser doesn't support javascript.
loading
Clinical efficacy and tolerability of 1.5 g/day oral amoxicillin therapy without probenecid for the treatment of syphilis.
Ikeuchi, Kazuhiko; Fukushima, Kazuaki; Tanaka, Masaru; Yajima, Keishiro; Imamura, Akifumi.
  • Ikeuchi K; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Japan.
  • Fukushima K; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Japan fukushima-ngi@umin.ac.jp.
  • Tanaka M; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Japan.
  • Yajima K; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Japan.
  • Imamura A; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Japan.
Sex Transm Infect ; 98(3): 173-177, 2022 05.
Article en En | MEDLINE | ID: mdl-33782148

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sífilis / Infecciones por VIH Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sífilis / Infecciones por VIH Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article